GB1538542A - Oxime derivatives - Google Patents

Oxime derivatives

Info

Publication number
GB1538542A
GB1538542A GB2609876A GB2609876A GB1538542A GB 1538542 A GB1538542 A GB 1538542A GB 2609876 A GB2609876 A GB 2609876A GB 2609876 A GB2609876 A GB 2609876A GB 1538542 A GB1538542 A GB 1538542A
Authority
GB
United Kingdom
Prior art keywords
oxime derivatives
oxime
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2609876A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Wyeth and Brother Ltd filed Critical John Wyeth and Brother Ltd
Priority to GB2609876A priority Critical patent/GB1538542A/en
Publication of GB1538542A publication Critical patent/GB1538542A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
GB2609876A 1977-06-23 1977-06-23 Oxime derivatives Expired GB1538542A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2609876A GB1538542A (en) 1977-06-23 1977-06-23 Oxime derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2609876A GB1538542A (en) 1977-06-23 1977-06-23 Oxime derivatives

Publications (1)

Publication Number Publication Date
GB1538542A true GB1538542A (en) 1979-01-24

Family

ID=10238348

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2609876A Expired GB1538542A (en) 1977-06-23 1977-06-23 Oxime derivatives

Country Status (1)

Country Link
GB (1) GB1538542A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002079156A1 (en) * 2001-03-30 2002-10-10 Astrazeneca Ab Novel piperidine derivatives as modulators of chemokine receptor
US6903085B1 (en) 1999-08-24 2005-06-07 Astrazeneca, Ab Substituted piperidine compounds useful as modulators of chemokine receptor activity
US6958350B2 (en) 2001-02-19 2005-10-25 Astrazeneca Ab Chemical compounds
US6960602B2 (en) 2001-03-22 2005-11-01 Astrazeneca Ab Piperidine derivatives as modulators of chemokine receptors
US7192973B2 (en) 2001-11-15 2007-03-20 Astrazeneca Ab Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5)
US7294636B2 (en) 2003-05-09 2007-11-13 Astrazeneca Ab Chemical compounds

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6903085B1 (en) 1999-08-24 2005-06-07 Astrazeneca, Ab Substituted piperidine compounds useful as modulators of chemokine receptor activity
US6958350B2 (en) 2001-02-19 2005-10-25 Astrazeneca Ab Chemical compounds
US6960602B2 (en) 2001-03-22 2005-11-01 Astrazeneca Ab Piperidine derivatives as modulators of chemokine receptors
WO2002079156A1 (en) * 2001-03-30 2002-10-10 Astrazeneca Ab Novel piperidine derivatives as modulators of chemokine receptor
US7192973B2 (en) 2001-11-15 2007-03-20 Astrazeneca Ab Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5)
US7294636B2 (en) 2003-05-09 2007-11-13 Astrazeneca Ab Chemical compounds

Similar Documents

Publication Publication Date Title
IL55387A0 (en) Triphenylalkene derivatives
AU4113878A (en) 1-alkanoyl-proline derivatives
GB2003876B (en) Beta-haloethylamine derivatives
NZ186175A (en) Meta-sulphonamidobenzamide derivatives
EG13665A (en) 2-imino-imidazolidine derivatives
AU3888578A (en) 4-hydroxy-2-benzimidazolinone derivatives
GB2009180B (en) 25-alkylcholestrerol derivatives
GB2009150B (en) Tetrahydrophtalamide derivatives
SG59183G (en) Prostanol derivatives
PH14637A (en) Oxadiazolopyrimidine derivatives
GB2005261B (en) 2-oxazolydone derivatives
GB1538542A (en) Oxime derivatives
PH13915A (en) Chinazoline derivatives
IL56042A0 (en) Prostanglandin derivatives
GB2014131B (en) 1-hydrocarbylpyrrole derivatives
GB2003479B (en) 3-amino-17alpha-aza-d-homoandrostane derivatives
PH15376A (en) 5-phenyl-1h-3-benzazepine derivatives
NZ188863A (en) 2-oxo-hexahydroazepine -piperidine and -pyrrolidine derivatives
AU3313978A (en) Everninomicin derivatives
GB2000128B (en) 15-substituted-omega-pentanorprostaglandin derivatives
GB2000769B (en) 4 - homoisotwistane derivatives
GB2008119B (en) Arylsteroid derivatives
IL54973A0 (en) 3-pyridylhydroxy-prop-1-ene derivatives
AU4129978A (en) Eburnamenine derivatives
GB2060630B (en) Pyrazinoquinoline derivatives

Legal Events

Date Code Title Description
PS Patent sealed
746 Register noted 'licences of right' (sect. 46/1977)
PCNP Patent ceased through non-payment of renewal fee